Библиография

Burk RF, Schaffner W, Koenig MG. Severe influenza virus pneumonia in the pandemic of 1968-1969. Arch Intern Med 1971; 127: 1122-1128.
Collins SD, Lehman, J. Excess deaths from influenza and pneumonia and from important chronic diseases during epidemic periods, 1918-51. Public Health monographs 1953; 10: 1-21.

Dolin R. Influenza. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, editors. HarrisonХs principles of internal medicine. USA: Library of Congress 1991; 695-700.

Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis 1987; 136: 550-555.

Jones A, Macfarlane J, Pugh S. Antibiotic therapy, clinical features and outcome of 36 adults presenting to hospital with proven influenza: do we follow guidelines? Postgrad Med 1991; 67: 988-990.

Kaye D, Rosenbluth M, Hook EW, Kilbourne ED. Endemic influenza. II The nature of the disease in the post-pandemic period. Am Rev Respir Dis 1961; 85: 9-21.

LaForce FM, Nichol KL, Cox NJ. Influenza: virology, epidemiology, disease, and prevention. Am J Prev Med 1994; 10: 31-44.

Leebeek FWG, Baggen MGA, Mulder LJMM, Dingemans-Dumas AM. Rhabdomyolysis associated with influenza A virus infection. Neth J Med 1995; 46: 189-192.

Martin CM, Kunin CM, Gottlieb LS, Barnes MW, Liu C, Finland M. Asian influenza A in Boston, 1957-1958. I Observations in thirty-two influenza-associated fatal cases. Arch Intern Med 1959; 103: 515-531.

Martin CM, Kunin CM, Gottlieb LS, Finland M. Asian influenza A in Boston. II Severe staphylococcal pneumonia complicating influenza. Arch Intern Med 1959; 103: 532-542.

Middleton PJ, Alexander RM, Szymanski MT. Severe myositis during recovery from influenza. Lancet 1970; 2: 533-535.

Scheiblauer H, Reinacher M, Tashiro M, Rott R. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J Infect Dis 1992; 166: 783-791.

Schwarzmann SW, Adler JL, Sullivan RJ, Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med 1971; 127: 1037-1041.

Simon NM, Rovner RN, Berlin BS. Acute myoglobinuria associated with type A2 (Hong Kong) influenza. JAMA 1970; 212: 1704-1705.

Sperber SJ, Francis JB. Toxic shock syndrome during an influenza outbreak. JAMA 1987; 257: 1086-1087.

Stuart-Harris CH. Influenza and its complications - I. British Medical Journal 1966; 1: 149-150.

Stuart-Harris CH. Influenza and its complications - II. British Medical Journal 1966; 1: 217-8.

Collard A. La grippe et son histoire. Revue M?dicale de Bruxelles 1974; 30: 61-77.

de Gooijer AC. In: De Spaanse Griep van Х18. Edited by Philips-Duphar Amsterdam. ISBN 90 6278 7517, 1978; 108-109.

de Jong JC, Paccaud MF, DeRonde-Verloop FM et al. Isolation of swine-like influenza A(H1N1) viruses from man in Switzerland and the Netherlands. Ann Inst Pasteur/Virol 1988; 139: 429-437.

Dowdle WR. Fort-Dix episode. The 1976 experience. J Infect Dis (Suppl 1) 1997: S69-72.

Ghendon Y. Introduction to Pandemic Influenza through History. Euro J Epidemiol 1994; 10: 451-453.

Hannoun C. La grippe. Annales de lХInstitut Pasteur 1995; 6 (1): 30-36.

Hirsch A. Handbook of geographical and historical pathology. 1. Translated by C Creichton, New Sydenham Society London, 1883.

Marwick C. Readiness is all: Public Health experts draft plan outlining pandemic influenza response. JAMA 1996; 275: 179-180.

Noble ER. Epidemiological and clinical aspects of influenza. In: Basic and Applied Influenza Research. Ed. AS Beare. Pub CRC Press Inc. Boca Raton, Florida, 1982.

Stuart-Harris CH. Virus of the 1968 Influenza pandemic. Nature 1970; 225: 850-851.

Stuart-Harris CH, Schild GC and Oxford JS. Influenza: the viruses and the disease. Pub Edward Arnold. 1985.

Taubenberger JK, Reid AH, Krafft AE et al. Initial genetic characterization of the 1918 ФSpanishХ influenza virus. Science 1997; 275: 1793-1796.

Wells DL, Hopfensperger DJ, Arden NH, Harmon MW, Davis JP, Tipple MA, Schonberger LB. Swine influenza virus infections. Transmission from ill pigs to humans at a Wisconsin agricultural fair and subsequent probable person-to-person transmission. JAMA 1991; 265(4): 478-81.

Claas EC, Jawaoka Y, de Jong JC et al. Infection of Children with Avian-Human Reassortant Influenza virus from pigs in Europe. Virology 1994; 204: 453-457.

Kurtz J, Manvell RJ and Banks, J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet 1996; 348: 901-902.

Schild G, Robertson J and Wood J. Influenza viruses and vaccines. In: viral and other infections of the human respiratory tract 1. Ed S Myint and D Taylor-Robinson. Pub: Chapman and Hall 1996: 251-274.

Scholtissek C. Molecular aspects of the epidemiology of virus disease. Experiment 1987; 43: 1197-2001.

Taubenberger JK, Reid AH, Krafft AE et al. Initial genetic characterization of the 1918 'Spanish' influenza virus. Science 1997; 275: 1793-1796.

Webster RG, Bean WJ, Gorman TO et al. Evolution and ecology of influenza A viruses. Microbiol 1992; 56: 159-179.

WHO. Recommended composition of influenza virus vaccines for use in the 1998-1999 season. Weekly Epidemiological Record 1998; 73: 56-63.

National Vaccine Program Office Pandemic Influenza: A Planning Guide for State and Local

INFLUENZA Fact Sheet No 211 February 1999 WHO information

INFLUENZA A(H5N1) Fact Sheet No 188 January 1998

Centers for Disease Control and Prevention: INFLUENZA

Orthomyxoviruses Robert B. Couch

National Foundation for Infectious Diseases: Symptoms

National Foundation for Infectious Diseases: The Virus Structure

Myxoviruses

Frequently asked questions on Flu Public health Laboratory service

Fleming DM and Cohen JM. Experience of European Collaboration in Influenza surveillance in the winter 1993-1994. J. Public Health Medicine 18, 133-142, 1996.

Snacken R, Bensadon M,Strauss A. The CARE Telematics Network for the surveillance of influenza in Europe. Methods of Information in Medicine, 1995, 34, 518-22.

Snacken R, Manuguerra JC, Taylor P. European Influenza Surveillance Scheme on the Internet. Method of Information in Medicine, 1998, 37, 266-270.

Zambon M. Sentinel Surveillance of influenza in Europe, 1997/1998. Eurosurveillance Vol. 3- no 3 March 1998.

Zambon M, van der Werf S., Rebelo de Andrade H. European Influenza Surveillance Scheme. Combined clinical and virological surveillance and data exchange through the internet. poster August 1998 Hannover.

THE WHO INFLUENZA PROGRAMME Fact Sheet No 212 February 1999

Н.А. Малышев, К.З. Смагулов "Дифференциальная диагностика". Медицина для всех № 3 (14), 1999

Справочник-путеводитель практикующего врача. Гл. редакторы И.Н.Денисов, Э.Г.Улумбеков. М., "ГЭОТАР Медицина" 1998 г.

Руководство по медицине. Диагностика и терапия. Гл. редактор Роберт Берклоу. М., "Мир" 1997 г.

Н.В Медуницын. Вакцинология. М., "Триада-Х", 1999 г.

Бактерийные, сывороточные и вирусные лечебно-профилактические препараты. Аллергены. Дезинфекционо-стерилизационные режимы поликлиник. Справочник практического врача. под ред. Н.А. Озерецковского, Г.И. Останина. Санкт-Петербург, "Фолиант", 1998 г.

Р.Я. Мешкова. Иммнопрофилактика. Руководство для врачей. Смоленск, "Русич" 1999 г.

ГРИПП И ВАКЦИНОПРОФИЛАКТИКА ГРИППА: эпидемиологический и экономический аспекты. Русский Медицинский Журнал, том 6 №22 1998 г.

Лечение

Belshe RB, Burk B, Newman F, Cerruti RL and Sim IS. Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. J Infect Dis 1989; 159: 430-435.
Dolin R, Reichman RC, Madore HP, Maynard R, Linton PM and Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307: 580-584.

Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG and Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989; 321: 1696-1702.

Oxford J and Al-Jabri A. Specific antiviral therapy of respiratory viruses. In: viral and other infections of the human respiratory tract 1. Ed. S. Myint and D. Taylor-Robinson. Pub: Chapman and Hall 1996: 397-420.

WHO. Current status of amantadine and rimantadine as anti-influenza A agents: memorandum from a WHO meeting. Bull WHO 1985; 63: 51-56.

ANTIVIRAL DRUGS FOR INFLUENZA Centers for Disease Control and Prevention

Neuraminidase Inhibitors for Treatment of Influenza A and B Infections MMWR Recommendations and Reports December 17, 1999 / 48(RR14);1-9

В.Ф. УЧАИКИН, член-корреспондент РАМН, профессор, заведующий кафедрой детских инфекций РГМУ, главный детский инфекционист МЗ РФ. При участии О.В. ШАМШЕВОЙ, директора центра вакцинопрофилактики "Диавакс", кандидата медицинских наук. "Как лечить грипп" Медицина для всех № 3 (14), 1999.

"Инфлюэнца, испанка, или просто грипп" Сестринское дело №6 1997

Руководство по медицине. Диагностика и терапия. Гл. редактор Роберт Берклоу. М., "Мир" 1997 г.

Профилактика

"Эффективность иммунопрофилактики гриппа субъединичной вакциной Инфлювак у детей с соматической патологией". Авторы: О.В.Шамшева, В.Ф. Учайкин, Е.И. Бурцева, А.Н. Слепушкин, И.Н. Новикова, Г.А. Ельшина. Российский вестник перинатологии и педиатрии. Том 45, 4'2000
"Иммунизация против гриппа. Часть 1: Проводимая в настоящее время политика вакцинации против гриппа и создание новых вакцин". A.M. Palache, I.A. de Bruijn and J. Nauta. In: Journal of Clinical Research,1999

"Иммунизация против гриппа. Часть 2: 15-летний опыт применения субъединичной гриппозной вакцины". A.M. Palache, I.A. de Bruijn and J. Nauta. In: Journal of Clinical Research,1999

"Сравнение серологии и реактогенности субъединичных вакцин, цельновирионных вакцин и вакцин из разрушенных вирусов. Обзор и мета-анализ литературных данных".
WEP Beyer, A.M. Palache and A.D.M.E. Osterhaus In: Clinical Drug Investigation, 1998, vol 15(1), pp:1-12.

"Influenza Vaccines: A Reappraisal of Their Use"
A.M. Palache. In: Drugs, 1997, vol 6, pp 841-856.

"Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines. A review and meta-analysis of the literature".
WEP Beyer, A.M. Palache and A.D.M.E. Osterhaus In: Clinical Drug Investigation, 1998, vol 15(1), pp:1-12.

"Influenza immunisation I: Influenza vaccination policies and new vaccine developments. II: Fifteen years experience with a subunit influenza vaccine". A.M. Palache, I.A. de Bruijn and J. Nauta.
In: Journal of Clinical Research,1999

"Influenza virus infections in infants".
W.P. Glezen, L.H. Taber, A.L. Frank, W.C. Gruber and P.A. Piedra In: Pediatr Infect Dis J, 1997, vol 16, pp 1065-1068.

"Factors associated with influenza coverage among elderly: Role of health care personnel".
P.O. Hokanen, T. Keistinen and S-L Kivela. In: Public Health, 1996, vol 110, pp 163-168.

"Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens".
K.L. Nichol, J. Wuorenma and T. von Sternberg. In: Archives of Internal Medicine, 1998, vol 158(16), pp 1769-1776

"Annually repeated influenza vaccination in elderly people".
I.A. de Bruijn. Thesis Leiden University, Leiden, The Netherlands, 1998.

"Результаты изучения эффективности гриппозной инактивированной субъединичной гриппозной вакцины «Инфлювак»" М.А. Горбунов, Г.А. Ельшина ГИСК им. Л.А. Тарасевича МЗРФ. Международный журнал медицинской практики. №9, 2000 г.

"Эффективность гриппозной вакцины при иммунизации работников здравоохранения. Рандомизированное клиническое испытание" Джеймс А. Уальд, Джулия А. Макмиллан, Джанет Сервинт, Джин Бутта, Мэри Энн О’Риордан, Марк К. Стейнхолф
JAMA, March 10, 1999 – Vol. 281, No. 10

"Субъединичная гриппозная вакцина: десятилетний опыт применения"
A.M. Palache. European Journal of Clinical Research 1992; 3:117–138

"Гриппозные вакцины: обзорное исследование их применения"
A.M. Palache. In: Drugs, 1997, vol 6, pp 841-856

"Safety, Reactogenicity and Immunogenicity of Madin Darby Canine Kidney Cell-Derived Inactivated Influenza Subunit Vaccine"
AM Palache, HSJ Scheepers, V de Regt, P van Ewijk, M Baljet, R Brands, GJM van Scharrenburg. In: Inactivated Influenza Vaccines Prepared in Cell Culture. Dev Biol Stand. Basel, Karger, 1999, vol 98, pp 115-125.

"Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA study. Study for the evaluation of adverse events of influenza vaccination"
S Spila-Alegiani, S Salmaso, MC Rota, AE Tozzi, R Raschetti.
In: Vaccine, 1999, vol 17, pp 1898-1904.

"Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs)"
R Glьck In: Vaccine, 1999, vol 17, pp 1782-1787

В стране эпидемия гриппа. Наш аист N 04(48), март 1999 г.

National Foundation for Infectious Diseases: Vaccination and Treatment

National Foundation for Infectious Diseases: Who Should Not Get The Vaccination?

National Foundation for Infectious Diseases: Who Should Get The Vaccination?

Influenza and Pneumococcal Vaccination Levels Among Adults Aged greater than or equal to 65 Years -- United States MMWR Weekly, October 02, 1998 / 47(38);797-802

General Recommendations for Preventing Influenza Infection Among Travelers CDC

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recommendations and Reports April 30, 1999 / 48(RR-04);1-28

Questions and Answers About Preventing Influenza Infection Among Travelers CDC

VACCINE INFORMATION

АРБИДОЛ

Lasky T et al. The Guillian-Barre Syndrome and the 1992-1993 and 1993-1994 influenza vaccines. NEJM 1998, 339, 25:1797-1802.

Ropper AH, Victor M. Influenza vaccination and the Guillian-Barr? Syndrome. NEJM 1998, 339, 25:1845-6.

Ghendon Y. Influenza Vaccines: A Main Problem in Control of Pandemics. Euro J Epidemiology 1994; 10: 485-486.

National Vaccine Program Office Pandemic Influenza: A Planning Guide for State and Local

"Vaccine Information Statement Influenza (4/14/00) Centers for Disease Control and Prevention National Immunization Program"

Fleming DM and Cohen JM. Experience of European Collaboration in Influenza surveillance in the winter 1993-1994. J. Public Health Medicine 18, 133-142, 1996.

Snacken R, Bensadon M,Strauss A. The CARE Telematics Network for the surveillance of influenza in Europe. Methods of Information in Medicine, 1995, 34, 518-22.

Snacken R, Manuguerra JC, Taylor P. European Influenza Surveillance Scheme on the Internet. Method of Information in Medicine, 1998, 37, 266-270.

Zambon M. Sentinel Surveillance of influenza in Europe, 1997/1998. Eurosurveillance Vol. 3- no 3 March 1998.

How to Avoid the Flu by Evelyn Zamula November 1994 FDA Consumer.

THE WHO INFLUENZA PROGRAMME Fact Sheet No 212 February 1999

Belshe RB, Burk B, Newman F, Cerruti RL and Sim IS. Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. J Infect Dis 1989; 159: 430-435.

Dolin R, Reichman RC, Madore HP, Maynard R, Linton PM and Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307: 580-584.

Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG and Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989; 321: 1696-1702.

WHO. Current status of amantadine and rimantadine as anti-influenza A agents: memorandum from a WHO meeting. Bull WHO 1985; 63: 51-56.

ANTIVIRAL DRUGS FOR INFLUENZA Centers for Disease Control and Prevention

Н.В Медуницын. Вакцинология. М., "Триада-Х", 1999 г.

Р.Я. Мешкова. Иммнопрофилактика. Руководство для врачей. Смоленск, "Русич" 1999 г.

Поиск по сайту

Рассылка новостей по e-mail


		Сайт создан при содействии международной фармацевтической компании "Solvay Pharma". Информация, представленная на данном сайте, не должна использоваться для самостоятельной диагностики и лечения и не может служить заменой очной консультации врача.